<DOC>
	<DOCNO>NCT02069132</DOCNO>
	<brief_summary>The purpose study validate International Warfarin Pharmacogenetics Consortium ( IWPC ) algorithm prospective cohort elderly people ( 65 year old ) heart valves and/or nonvalvular atrial fibrillation ( AF ) least one comorbid condition , assess algorithm 's prognostic relevance .</brief_summary>
	<brief_title>Validation International Warfarin Pharmacogenetics Consortium ( IWPC ) Algorithm Elderly Patients With Comorbidity</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Age â‰¥ 65 year Patients initiate warfarin non valvular atrial fibrillation heart valve replacement At least one comorbid condition At least two drug regularly assume warfarin Presence systemic coagulopathies Presence malignancy need chemotherapy Inability refusal give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Warfarin</keyword>
	<keyword>International Warfarin Pharmacogenetics Consortium algorithm</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Heart Valve Prosthesis Implantation</keyword>
	<keyword>elderly</keyword>
	<keyword>comorbidity</keyword>
</DOC>